Imeka sits in the diffusion MRI analytics market, offering software that extracts clinically useful microstructural biomarkers from complex imaging datasets. Its value proposition is strongest in turning high-dimensional diffusion data into decision-support outputs, though it competes in a specialist segment with relatively long sales cycles.